This document summarizes collaboration between tuberculosis (TB) and HIV civil society organizations (CSOs) and HIV/TB programs in Ukraine. It notes that in 2012 there were over 20,000 new HIV cases and nearly 31,000 new TB cases reported in Ukraine. Only 44% of HIV-positive TB patients started antiretroviral therapy. Key challenges to integration include the vertical nature of Ukraine's health system, lack of cooperation between AIDS and TB services, and limited collaboration with CSOs. The document outlines efforts by the International HIV/AIDS Alliance in Ukraine to strengthen collaboration through a memorandum of understanding and expanding TB services among organizations working with most-at-risk populations.
This document summarizes recent measles outbreaks and epidemiology in Europe. It finds that measles remains endemic in 6 EU countries and that vaccination coverage for the first and second dose of the MMR vaccine remains below 95% in over half of reporting countries. Outbreaks in 2017 have already exceeded case numbers for all of 2016 in some countries. The majority of recent cases are in unvaccinated individuals, especially children ages 1-4 who are the target group for routine vaccination. Several outbreaks have also affected healthcare workers. Actions are needed to strengthen routine childhood vaccination and increase vaccination rates to eliminate measles transmission.
Influenza, or the flu, poses a serious threat in the United States, resulting in over 200,000 hospitalizations and 36,000 deaths annually. Healthcare workers can transmit influenza through coughs, sneezes, and contact with contaminated surfaces. There is debate around whether healthcare workers have an ethical duty to receive the influenza vaccine due to their role in caring for at-risk patients. Hospitals have implemented education programs and policies to increase vaccination rates among staff and prevent the spread of influenza within healthcare facilities.
1. The director of the EMCDDA discussed the evolution of HIV, drugs, and risk behavior in Europe based on lessons learned over decades. New HIV infections attributed to injecting drug use have declined significantly since the 1990s due to effective drug treatment and prevention programs.
2. However, regional disparities remain, and new outbreaks have been linked to stimulant use and new psychoactive substances. Maintaining prevention services and reaching vulnerable groups who are not in care will be important to address ongoing challenges.
3. Going forward, the EMCDDA aims to maintain understanding of drug use trends, identify new health threats to support rapid responses, promote effective interventions, and support policy development - all to contribute to
Lucia PASTORE CELENTANO, MD, MSc
Head of the Vaccine Preventable Diseases Programme, ECDC
“Addressing vaccine hesitancy in challenging times”
European Health Forum Gastein, 05 October 2017
the findings of a survey conducted by ECDC across EU/EEA countries that assessed the level of implementation of IIS and their functionalities, as well as the challenges encountered during the design and implementation. The aim of the survey was to share knowledge about IIS in the EU/EEA in order to build consensus on the characteristics of an optimal system and to describe differences in core functionalities and standards across countries.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 21st Congress of the European Association of Dental Public Health (1 October 2016 Budapest)
Presentation at the EU session "Elimination of hepatitis B and C in the EU: challenges and opportunities", at the International Liver Congress (ILC) 2017, Amsterdam.
Presenter: Dagmar Hedrich, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
This document summarizes recent measles outbreaks and epidemiology in Europe. It finds that measles remains endemic in 6 EU countries and that vaccination coverage for the first and second dose of the MMR vaccine remains below 95% in over half of reporting countries. Outbreaks in 2017 have already exceeded case numbers for all of 2016 in some countries. The majority of recent cases are in unvaccinated individuals, especially children ages 1-4 who are the target group for routine vaccination. Several outbreaks have also affected healthcare workers. Actions are needed to strengthen routine childhood vaccination and increase vaccination rates to eliminate measles transmission.
Influenza, or the flu, poses a serious threat in the United States, resulting in over 200,000 hospitalizations and 36,000 deaths annually. Healthcare workers can transmit influenza through coughs, sneezes, and contact with contaminated surfaces. There is debate around whether healthcare workers have an ethical duty to receive the influenza vaccine due to their role in caring for at-risk patients. Hospitals have implemented education programs and policies to increase vaccination rates among staff and prevent the spread of influenza within healthcare facilities.
1. The director of the EMCDDA discussed the evolution of HIV, drugs, and risk behavior in Europe based on lessons learned over decades. New HIV infections attributed to injecting drug use have declined significantly since the 1990s due to effective drug treatment and prevention programs.
2. However, regional disparities remain, and new outbreaks have been linked to stimulant use and new psychoactive substances. Maintaining prevention services and reaching vulnerable groups who are not in care will be important to address ongoing challenges.
3. Going forward, the EMCDDA aims to maintain understanding of drug use trends, identify new health threats to support rapid responses, promote effective interventions, and support policy development - all to contribute to
Lucia PASTORE CELENTANO, MD, MSc
Head of the Vaccine Preventable Diseases Programme, ECDC
“Addressing vaccine hesitancy in challenging times”
European Health Forum Gastein, 05 October 2017
the findings of a survey conducted by ECDC across EU/EEA countries that assessed the level of implementation of IIS and their functionalities, as well as the challenges encountered during the design and implementation. The aim of the survey was to share knowledge about IIS in the EU/EEA in order to build consensus on the characteristics of an optimal system and to describe differences in core functionalities and standards across countries.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 21st Congress of the European Association of Dental Public Health (1 October 2016 Budapest)
Presentation at the EU session "Elimination of hepatitis B and C in the EU: challenges and opportunities", at the International Liver Congress (ILC) 2017, Amsterdam.
Presenter: Dagmar Hedrich, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
ECDC poster at the 16th European AIDS Conference, 2017, Milan.
Authors: Lara Tavoschi, Joana Gomes-Dias, Anastasia Pharris, the EU/EEA HIV Surveillance Network
The WHO Health Emergencies Programme in the European Region focuses on several priority areas:
1) Country health emergency preparedness and International Health Regulations core capacity building.
2) Health emergency information and risk assessment through 24/7 monitoring and early detection of public health events.
3) Emergency operations management for graded health emergencies and coordination of partner responses.
4) Infectious hazard management including prevention and control strategies for high-threat pathogens.
The Programme operates through core services and is working to ensure countries have the capacities for all-hazards health emergency risk management.
Presentation by the Director-elect, Dr Andrea Ammon, for her hearing at the Environment, Public Health and Food Safety Committee of the European Parliament
Presented by Piroska Östlin, Director and Åsa Nihlén, Technical Officer, Division of Policy and Governance for Health and Well-being, WHO/Europe, at the 66th session of the WHO Regional Committee for Europe.
Opioid Substitution Therapy (OST) and TB/MDR integrationZahed Islam
This document discusses Ukraine's experience integrating tuberculosis (TB) screening and treatment into opioid substitution therapy (OST) sites. It finds that:
1) Over 9,000 people in Ukraine were diagnosed with multi-drug resistant TB in 2013, and OST sites are screening their over 8,000 patients for TB.
2) OST sites located in TB clinics and integrated care centers provide TB screening and treatment to their 301 patients, while basic OST sites serve 68 patients.
3) Studies found that OST patients had good access to TB diagnosis and treatment through collaboration between OST sites and on-site or nearby TB clinics and doctors.
Presentation by Sarah Rodgers, Professor of Health Informatics, University of Liverpool: Digital opportunities within academia at ECO: Digital Health in the North on Wednesday 27 September at Kings House Conference Centre, Manchester
This document is the NHS Atlas of Variation in Healthcare for People with Diabetes from May 2012. It summarizes that in 2010/11 there were over 2.4 million people in England diagnosed with diabetes, which is estimated to rise to over 3.8 million by 2020. It also discusses that treating diabetes is costly, with prescribing costs rising over 40% from 2005/06 to 2010/11. Additionally, it notes that many people with diabetes do not receive all recommended care processes and over 30% do not meet treatment targets for blood sugar and blood pressure levels.
This document is a curriculum vitae for Muhammed Ahmed Rameto. It outlines his personal and educational background, work experience, skills, and references. Currently, he is the CEO of Kulito Hospital in SNNPR, Ethiopia, where his responsibilities include overseeing medical staff, planning activities, improving access to healthcare services, and collaborating with partners. Previously, he worked as the Head of Halaba special woreda health office, managing rural and urban health programs related to reproductive health, child health, nutrition, malaria, and HIV/AIDS. He has a Bachelor's degree in natural science and a Master's in public health epidemiology.
Who workshop aids 2014 hivtb integrationZahed Islam
This document summarizes an AIDS 2014 workshop on increasing access to tuberculosis (TB) services for people who inject drugs in Ukraine through integrated care. It describes how non-governmental organizations (NGOs) in Ukraine provide TB screening, testing, and treatment to people who inject drugs through outreach programs and by establishing integrated care centers that provide medical and psychosocial support services for patients with drug abuse, HIV, and TB comorbidities in a single location. As of 2014, these efforts had established 88 opioid substitution therapy sites and detected 659 TB cases through screening over 10,000 people who inject drugs. However, challenges remain around resource limitations, regulatory guidance, technical capacity, and stigma.
MDR-TB continues to ravage Europe, making it the most affected region globally. Only 50% of MDR-TB patients are detected and half of those successfully treated. This calls for increased access to new TB drugs, faster diagnosis, and patient-centered care as advocated in the new End TB Strategy and European action plan. While TB rates are declining in Europe, nearly 1,000 new cases still occur daily, with high burdens in 18 priority countries where 84% of cases and 90% of deaths occur. MDR rates remain high, underscoring the need for better detection and treatment in Europe.
Factors associated adherence to TB treatment in Georgia report (eng)Ina Charkviani
This document summarizes a study on barriers and facilitators to adherence to treatment among drug resistant tuberculosis (DR-TB) patients in Georgia. The study identified several key factors that influence patient adherence through in-depth interviews and focus groups with patients, providers, and experts. These factors were grouped into structural, social, personal, and health system categories. The study aims to understand reasons for loss to follow-up and inform recommendations to improve treatment outcomes.
The document summarizes key points from a presentation on developing a Model of Care to address tuberculosis (TB) in London. It outlines three main aspects the model aims to improve: 1) detection and diagnosis of TB through raising awareness in high-risk communities and among healthcare workers, and piloting active/latent case finding; 2) coordinated commissioning of TB services; and 3) reducing variability in service provision across London. The model was developed through extensive stakeholder engagement to address increasing TB rates in London and risks of further fragmentation, unequal care, and drug-resistant TB without changes to the current system.
Public Health - Incidence Prevalence Prevention of HIV in the UK - government situation report 2015 - improving the nations health - Impact on budget nhs england - care quality commission - health tourism - migrant burden - healthcare - hospitals treating disease.
Poster presentation at the AIDS 2018 conference in Amsterdam.
By: Marieke J. van der Werf and Csaba Ködmön, European Centre for Disease Prevention and Control, ECDC.
Evaluation of the factors that contribute to high prevalence of malaria in HI...PUBLISHERJOURNAL
Evaluation of the factors that contribute to high prevalence of malaria in HIV Patients in Bushenyi District, Uganda
Kakuru James
Faculty of Nursing Sciences Kampala International University, Uganda.
________________________________________
ABSTRACT
Malaria remains the single main cause of ill health and death among HIV/AIDS patients in resource-poor countries worldwide. Malaria still remains a challenging infection affecting the lives of several HIV-infected persons in Uganda. Statistics from the Ministry of Health show that malaria is still the leading cause of death in Uganda, accounting for over 27% of deaths. Malaria prevalence in HIV-positive patients in Kyamuhunga Health Centre III is thought to be at 7.8% of the HIV-positive patients attending the clinic on a daily basis. This study therefore aimed at assessing the factors contributing to the high prevalence of malaria among HIV-positive patients attending the HIV Clinic at Kyamuhunga Health Centre III in Bushenyi District. The study covered a sample of eighty (80) respondents to gather primary data. A simple random sampling method was used to gather responses from patients. Questionnaires and an interview guide were used as data collection tools. Results indicated that the majority of the participants were female patients and malaria was dominant among HIV-positive patients aged 38-47 years. It was noted that the odds of having malaria also increased among patients with lower levels of education. It was also noted that more odds of having malaria were found among the majority of patients who were farmers and unemployed participants. Malaria infection was acquired with repeated exposure to malaria parasites especially for patients who did not use insecticide treated mosquito nets. It is noted that HIV-positive patients with malaria greatly acquired unbalanced immunity with relatively low CD4+ cell count and unbalanced hemoglobin levels, greatly affected by body pain and weakness, fever, headache, and variety issues of vomiting. Paracetamol, use of treated mosquito nets, clinical examination, and patient follow-up was shown to provide a beneficial effect in preventing malaria infection among HIV-positive patients. In conclusion, malaria infection is acquired from repeated exposure to malaria parasites especially for patients who did not use Treated mosquito nets which increased the susceptibility to new malaria infections among HIV-positive patients. The researcher, therefore, recommends that comprehensive health education, antiretroviral therapy, and malaria preventive materials such as insecticide-treated bed nets should be provided to reduce the prevalence of malaria among HIV-positive patients.
Keywords: Malaria, HIV patients, Treated mosquito nets, Antiretroviral therapy.
Trans R Soc Trop Med Hyg-2015-Mohr-trstmh-trv037Erika Mohr
This study assessed treatment outcomes for 853 HIV-infected and uninfected patients with drug-resistant tuberculosis (DR-TB) treated in Khayelitsha, South Africa between 2008-2012. The study found that HIV status did not impact time to sputum culture conversion or treatment success rates. Mortality during treatment was higher in HIV-infected patients, but overall mortality was not significantly different between the groups. HIV-infected patients with a CD4 count ≤100 cells/ml were more likely to die after starting treatment. The study concluded that DR-TB treatment outcomes did not differ based on HIV status in a program with integrated HIV/TB care including antiretroviral treatment (ART). Earlier ART for those with low
Early TB detection and treatment efficiency among MARP'sZahed Islam
This document summarizes a project in Ukraine that worked to enhance early tuberculosis (TB) detection and treatment efficiency among at-risk populations. Non-governmental organizations screened over 10,000 people and detected 659 TB cases total, including 542 newly diagnosed or relapse cases. The project helped improve access to TB care for vulnerable groups and expanding these detection efforts through NGOs can further reduce TB spread and mortality among high-risk populations in Ukraine.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sophocles Chanos
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
ECDC poster at the 16th European AIDS Conference, 2017, Milan.
Authors: Lara Tavoschi, Joana Gomes-Dias, Anastasia Pharris, the EU/EEA HIV Surveillance Network
The WHO Health Emergencies Programme in the European Region focuses on several priority areas:
1) Country health emergency preparedness and International Health Regulations core capacity building.
2) Health emergency information and risk assessment through 24/7 monitoring and early detection of public health events.
3) Emergency operations management for graded health emergencies and coordination of partner responses.
4) Infectious hazard management including prevention and control strategies for high-threat pathogens.
The Programme operates through core services and is working to ensure countries have the capacities for all-hazards health emergency risk management.
Presentation by the Director-elect, Dr Andrea Ammon, for her hearing at the Environment, Public Health and Food Safety Committee of the European Parliament
Presented by Piroska Östlin, Director and Åsa Nihlén, Technical Officer, Division of Policy and Governance for Health and Well-being, WHO/Europe, at the 66th session of the WHO Regional Committee for Europe.
Opioid Substitution Therapy (OST) and TB/MDR integrationZahed Islam
This document discusses Ukraine's experience integrating tuberculosis (TB) screening and treatment into opioid substitution therapy (OST) sites. It finds that:
1) Over 9,000 people in Ukraine were diagnosed with multi-drug resistant TB in 2013, and OST sites are screening their over 8,000 patients for TB.
2) OST sites located in TB clinics and integrated care centers provide TB screening and treatment to their 301 patients, while basic OST sites serve 68 patients.
3) Studies found that OST patients had good access to TB diagnosis and treatment through collaboration between OST sites and on-site or nearby TB clinics and doctors.
Presentation by Sarah Rodgers, Professor of Health Informatics, University of Liverpool: Digital opportunities within academia at ECO: Digital Health in the North on Wednesday 27 September at Kings House Conference Centre, Manchester
This document is the NHS Atlas of Variation in Healthcare for People with Diabetes from May 2012. It summarizes that in 2010/11 there were over 2.4 million people in England diagnosed with diabetes, which is estimated to rise to over 3.8 million by 2020. It also discusses that treating diabetes is costly, with prescribing costs rising over 40% from 2005/06 to 2010/11. Additionally, it notes that many people with diabetes do not receive all recommended care processes and over 30% do not meet treatment targets for blood sugar and blood pressure levels.
This document is a curriculum vitae for Muhammed Ahmed Rameto. It outlines his personal and educational background, work experience, skills, and references. Currently, he is the CEO of Kulito Hospital in SNNPR, Ethiopia, where his responsibilities include overseeing medical staff, planning activities, improving access to healthcare services, and collaborating with partners. Previously, he worked as the Head of Halaba special woreda health office, managing rural and urban health programs related to reproductive health, child health, nutrition, malaria, and HIV/AIDS. He has a Bachelor's degree in natural science and a Master's in public health epidemiology.
Who workshop aids 2014 hivtb integrationZahed Islam
This document summarizes an AIDS 2014 workshop on increasing access to tuberculosis (TB) services for people who inject drugs in Ukraine through integrated care. It describes how non-governmental organizations (NGOs) in Ukraine provide TB screening, testing, and treatment to people who inject drugs through outreach programs and by establishing integrated care centers that provide medical and psychosocial support services for patients with drug abuse, HIV, and TB comorbidities in a single location. As of 2014, these efforts had established 88 opioid substitution therapy sites and detected 659 TB cases through screening over 10,000 people who inject drugs. However, challenges remain around resource limitations, regulatory guidance, technical capacity, and stigma.
MDR-TB continues to ravage Europe, making it the most affected region globally. Only 50% of MDR-TB patients are detected and half of those successfully treated. This calls for increased access to new TB drugs, faster diagnosis, and patient-centered care as advocated in the new End TB Strategy and European action plan. While TB rates are declining in Europe, nearly 1,000 new cases still occur daily, with high burdens in 18 priority countries where 84% of cases and 90% of deaths occur. MDR rates remain high, underscoring the need for better detection and treatment in Europe.
Factors associated adherence to TB treatment in Georgia report (eng)Ina Charkviani
This document summarizes a study on barriers and facilitators to adherence to treatment among drug resistant tuberculosis (DR-TB) patients in Georgia. The study identified several key factors that influence patient adherence through in-depth interviews and focus groups with patients, providers, and experts. These factors were grouped into structural, social, personal, and health system categories. The study aims to understand reasons for loss to follow-up and inform recommendations to improve treatment outcomes.
The document summarizes key points from a presentation on developing a Model of Care to address tuberculosis (TB) in London. It outlines three main aspects the model aims to improve: 1) detection and diagnosis of TB through raising awareness in high-risk communities and among healthcare workers, and piloting active/latent case finding; 2) coordinated commissioning of TB services; and 3) reducing variability in service provision across London. The model was developed through extensive stakeholder engagement to address increasing TB rates in London and risks of further fragmentation, unequal care, and drug-resistant TB without changes to the current system.
Public Health - Incidence Prevalence Prevention of HIV in the UK - government situation report 2015 - improving the nations health - Impact on budget nhs england - care quality commission - health tourism - migrant burden - healthcare - hospitals treating disease.
Poster presentation at the AIDS 2018 conference in Amsterdam.
By: Marieke J. van der Werf and Csaba Ködmön, European Centre for Disease Prevention and Control, ECDC.
Evaluation of the factors that contribute to high prevalence of malaria in HI...PUBLISHERJOURNAL
Evaluation of the factors that contribute to high prevalence of malaria in HIV Patients in Bushenyi District, Uganda
Kakuru James
Faculty of Nursing Sciences Kampala International University, Uganda.
________________________________________
ABSTRACT
Malaria remains the single main cause of ill health and death among HIV/AIDS patients in resource-poor countries worldwide. Malaria still remains a challenging infection affecting the lives of several HIV-infected persons in Uganda. Statistics from the Ministry of Health show that malaria is still the leading cause of death in Uganda, accounting for over 27% of deaths. Malaria prevalence in HIV-positive patients in Kyamuhunga Health Centre III is thought to be at 7.8% of the HIV-positive patients attending the clinic on a daily basis. This study therefore aimed at assessing the factors contributing to the high prevalence of malaria among HIV-positive patients attending the HIV Clinic at Kyamuhunga Health Centre III in Bushenyi District. The study covered a sample of eighty (80) respondents to gather primary data. A simple random sampling method was used to gather responses from patients. Questionnaires and an interview guide were used as data collection tools. Results indicated that the majority of the participants were female patients and malaria was dominant among HIV-positive patients aged 38-47 years. It was noted that the odds of having malaria also increased among patients with lower levels of education. It was also noted that more odds of having malaria were found among the majority of patients who were farmers and unemployed participants. Malaria infection was acquired with repeated exposure to malaria parasites especially for patients who did not use insecticide treated mosquito nets. It is noted that HIV-positive patients with malaria greatly acquired unbalanced immunity with relatively low CD4+ cell count and unbalanced hemoglobin levels, greatly affected by body pain and weakness, fever, headache, and variety issues of vomiting. Paracetamol, use of treated mosquito nets, clinical examination, and patient follow-up was shown to provide a beneficial effect in preventing malaria infection among HIV-positive patients. In conclusion, malaria infection is acquired from repeated exposure to malaria parasites especially for patients who did not use Treated mosquito nets which increased the susceptibility to new malaria infections among HIV-positive patients. The researcher, therefore, recommends that comprehensive health education, antiretroviral therapy, and malaria preventive materials such as insecticide-treated bed nets should be provided to reduce the prevalence of malaria among HIV-positive patients.
Keywords: Malaria, HIV patients, Treated mosquito nets, Antiretroviral therapy.
Trans R Soc Trop Med Hyg-2015-Mohr-trstmh-trv037Erika Mohr
This study assessed treatment outcomes for 853 HIV-infected and uninfected patients with drug-resistant tuberculosis (DR-TB) treated in Khayelitsha, South Africa between 2008-2012. The study found that HIV status did not impact time to sputum culture conversion or treatment success rates. Mortality during treatment was higher in HIV-infected patients, but overall mortality was not significantly different between the groups. HIV-infected patients with a CD4 count ≤100 cells/ml were more likely to die after starting treatment. The study concluded that DR-TB treatment outcomes did not differ based on HIV status in a program with integrated HIV/TB care including antiretroviral treatment (ART). Earlier ART for those with low
Early TB detection and treatment efficiency among MARP'sZahed Islam
This document summarizes a project in Ukraine that worked to enhance early tuberculosis (TB) detection and treatment efficiency among at-risk populations. Non-governmental organizations screened over 10,000 people and detected 659 TB cases total, including 542 newly diagnosed or relapse cases. The project helped improve access to TB care for vulnerable groups and expanding these detection efforts through NGOs can further reduce TB spread and mortality among high-risk populations in Ukraine.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sophocles Chanos
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
This study evaluated the frequency and distribution of HIV/AIDS cases in Vlora, Albania from September 2012 to 2013. A total of 28 HIV/AIDS cases were reported from 1994 to 2013 in Vlora, with the highest frequency (7 cases) occurring in 2012. In 2012, 6 of the 7 cases were male and 5 were infected through heterosexual transmission. From 2012-2013, 10 total cases were reported with the majority (71%) transmitting through heterosexual contact and 29% transmitting vertically. The study concluded HIV infection rates have increased in the Balkan region and surveillance and prevention programs need strengthening, especially for at-risk groups.
Presentation on the Access and Delivery Partnership by Tenu Avafia, 3 April 2014.
The presentation covered:
-Impact of NTDs, TB and Malaria on development outcomes;
-Dual challenges of Innovation and Access;
-Government of Japan and UNDP Partnership: Addressing innovation & Access
-Access and Delivery Partnership: strengthening capacity across the health system
current hiv situation in india and national aids control programme an overviewikramdr01
The document provides information about an orientation programme for doctors on the National AIDS Control Programme (NACO) in India. It will take place on December 26-27, 2013 at the Government Thiruvarur Medical College and Hospital in Thiruvarur, India. The programme will provide an overview of the current HIV situation in India, NACO's objectives and approaches, national guidelines for detecting HIV, and NACO's comprehensive HIV care and antiretroviral therapy (ART) services.
Romania’s current tuberculosis (TB) problems illustrate the consequence of what happens when the challenges of such a disease are, for many years, met with lethargy rather than action. The country currently has about 1/4 of all TB cases in the EU and European Economic Area, even though it has just under 4% of the area’s total population. What are the main barriers to addressing TB in Romania? To what extent are there opportunities for change?
This document compares hepatitis C virus (HCV) epidemiology and prevention efforts in Poland and Switzerland. Some key points:
- HCV prevalence is similar in both countries (around 0.7-0.8%), though genotypes and transmission routes differ. Injection drug use is the main route in Switzerland while medical procedures historically drove transmission in Poland.
- Switzerland detects HCV at a higher rate, with around 6 new diagnoses per 100 estimated undiagnosed cases per year compared to 1 in Poland. Treatment rates also differ, at 4 per 100 estimated active infections in Switzerland and 2 in Poland.
- Mortality and advanced liver disease outcomes are higher in Switzerland currently, though rates in Poland may rise without improved screening and
This document discusses tuberculosis (TB) in Pakistan from a public health perspective. It begins with an introduction to TB, including how it spreads and its symptoms. It then discusses the epidemiology of TB in Pakistan, where it is one of the highest burden countries globally. The public health response to TB in Pakistan is also outlined, including the National TB Control Program, BCG vaccination, case detection, contact tracing, and infection control measures. Organizations working on TB control in Pakistan are described. The challenges to TB control and opportunities for progress are presented. Finally, the future prospects for TB elimination in Pakistan are discussed, including commitments to meet global targets.
Similar to Collaboration among TB/HIV CSOs and HIV and TB programs in Ukraine (20)
Community Workers competencies and learning needsZahed Islam
Post Graduate training provided in the 45th Union World lung health conference in Barcelona 2014 on "Defining community workers competencies and learning needs"
Early detection of TB cases in the community settingsZahed Islam
This document summarizes a presentation on early tuberculosis (TB) detection efforts among vulnerable groups in Ukraine. It discusses establishing screening and testing programs within 36 NGOs serving populations like sex workers, injecting drug users, and men who have sex with men. Key activities included training NGO staff, implementing screening questionnaires, collecting sputum samples on-site, and establishing referral pathways to healthcare facilities. Preliminary results showed improved access to TB services through the collaboration between NGOs and healthcare. However, motivation for clients to undergo TB testing remained low. Moving forward, over 75 NGOs will incorporate active TB detection and more training is needed to encourage clients to get tested and complete treatment if diagnosed.
Models of Holistic approach to OST patients in Integrated care settingsZahed Islam
This was presentation made at the OST conference in May 2012 to demonstrate different models of Integrated care that has been implemented by Alliance Ukraine in the country.
Expanding Medication Assisted Therapy in UkraineZahed Islam
Launching of a new 5 year Research project in partnership with Yale University School of Medicine on "Success and barriers of implementing Medicated Assisted Treatment (MAT) in UKraine"
Universal access to art policy in place 5 july11Zahed Islam
Regional Workshop on Drug Use and HIV in Eastern Europe and Central Asia was held in Kyiv, Ukraine from July 11-15, 2011 by PEPFAR. Ukraine has over 180,000 registered HIV cases but only around 22,000 receive antiretroviral therapy (ART), and less than 1% of those are active injection drug users. New HIV laws in Ukraine passed in 1991, 1998, and 2001 guarantee certain rights for people who inject drugs including access to harm reduction services, but policies have not been fully implemented and emerging policies threaten access to services for people who inject drugs. Ensuring equal access to prevention, treatment and care services for all populations remains a challenge.
The document summarizes efforts to integrate TB and HIV services in Ukraine. It describes challenges including a highly vertical healthcare system, lack of cooperation between AIDS and TB services, and ensuring access to quality second-line drugs for drug-resistant TB. Methods used to address this include establishing a TB/HIV working group, training health workers, and integrating prevention and treatment services. Outcomes include signing collaboration agreements and expanding integrated care services to over 1,000 clients. Further reforms are needed to fully integrate services and ensure long-term sustainability.
Presentation french red cross, Alliance Ukraine, march17 2010Zahed Islam
The International HIV/AIDS Alliance in Ukraine held a briefing meeting in March 2010 in Kiev. The Alliance has implemented $79 million in HIV programs since 2007, targeting at-risk groups like injecting drug users, female sex workers, men who have sex with men, and prisoners. Key programs include opioid substitution therapy, prevention services, medical and psychosocial support for HIV-positive injecting drug users, and capacity building for NGOs. However, challenges remain around stigma, criminalization of drug use, expanding HIV testing, decentralizing health services, and integrating social services with clinical care.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Collaboration among TB/HIV CSOs and HIV and TB programs in Ukraine
1. Collaboration among TB/HIV CSOs and HIV and
TB programs in UkraineUkraine
Zahedul IslamZahedul Islam
International HIV/AIDS Alliance in UkraineInternational HIV/AIDS Alliance in Ukraine
Wolfheze 2013
16th
Wolfheze Workshop
28-31 May 2013, The Hague,
The Netherlands
5. MoH TB/HIV Management Structure before 2012
www.aidsalliance.org.ua
Ministry of Health
State Services
Regional Healthcare Department
National TB CenterNational TB Center
Regional TB Dispensary and TB
Hospital
Regional TB Dispensary and TB
Hospital
National AIDS CenterNational AIDS Center
Regional AIDS CenterRegional AIDS Center
Infections
Disease
Laborator
y
Infections
Disease
Laborator
y
District
hospitals
District
hospitals
Polyclinic
s
Polyclinic
s
Cabinets
of trust
Cabinets
of trust
TB
laboratory
1-3 levels
TB
laboratory
1-3 levels
District
hospitals
District
hospitals
Polyclinic
s
Polyclinic
s
6
6. MoH TB/HIV Management Structure after 2012
www.aidsalliance.org.ua
Ministry of Health
State Servises
Regional Healthcare Department
Regional TB Dispensary and TB
Hospital
Regional TB Dispensary and TB
Hospital
Regional AIDS CenterRegional AIDS Center
Infections
Disease
Laborator
y
Infections
Disease
Laborator
y
District
hospitals
District
hospitals
Polyclinic
s
Polyclinic
s
Cabinets
of trust
Cabinets
of trust
TB
laboratory
1-3 levels
TB
laboratory
1-3 levels
District
hospitals
District
hospitals
Polyclinic
s
Polyclinic
s
7
Ukrainian Center for Disease Control (UCDC)
7. Alliance Ukraine in TB/HIV Management Structure
www.aidsalliance.org.ua
8
CSOs- co-chairs of National CCM
HP procurement (PSM)
Good Practices development
Cross-sectoral HIV/TB working groups (WG)
Trilateral memorandum among Ukrainian AIDS
Center, All-Ukrainian TB Control Center and
Alliance;
Biannual reporting meetings for TB and HIV
program managers
Technical support
Grants
Trainings
Advocacy
9. www.aidsalliance.org.ua
o CSOs- co-chairs of National CCM
o Capacity building of Ukrainian CDC
o Participation at MOH Working Groups on TB and TB/HIV
issues
o CSO’s are integral part of regional coordination council
meeting on HIV and TB
o R10 GF HIV grant is launching new initiative on TB/HIV
integrated activities
10
10. www.aidsalliance.org.ua
Key challenges – health system
• Highly vertical heath care system of Ukraine is a major
obstacle for integration of services.
• Frequent changes of management in the government
leadership
• Lack of cooperation between AIDS and TB services:
information sharing, joint planning, M&E performance
measures and indicators.
• Lack of adequate financing
• Poor infection control
• Rudimentary collaboration with CSO’s and HCF
11
11. www.aidsalliance.org.ua
Key challenges – CSO’s
Stigma and discrimination
Lack of recourses at NGOs to initiate implementation of
TB activities without additional support
Lack of CS representatives to address TB issues to the
government
No mechanisms and initiative to regulate affairs between
NGOs and TB HCF
Collaboration with CSO’s and MoH are rudimentary
Lack of technical capacity (technical knowledge about
disease and treatment)
12
12. Achievements
www.aidsalliance.org.ua
Signed a trilateral MoU among Ukrainian AIDS Center,
Ukrainian TB Control Center and Alliance Ukraine on
partnership and collaboration Involvement of the CSOs
into the TB/HIV activities
Expansion of TB services among NGOs working with
MARPs (Projects on early TB diagnostics among
MARPs)
•Creation and coordination of TB/HIV reference group
•Representing CSOs needs at national level
•TB/HIV protocols and orders review
•Training on TB awareness among NGOs
•Integrated care services provision in TB clinics (HIV/TB/SMT)
13
13. www.aidsalliance.org.ua
- CSO’s participation in TB and TB/HIV activities is crucial to
successful implementation of TB programs
- Patient-oriented approach is needed for TB/HIV implementation
(DOTs, Stop TB strategy)
- CSO’s staff should be trained on TB issues to avoid new TB cases
among MARPs
-With the leadership from the Government a functional coordination
mechanism between all these services must be in place
- State financing is a cornerstone of sustainability
- Further develop and mobilize civil society to demand accountability
and to address stigma and discrimination
14
14. www.aidsalliance.org.ua
Good practice guide on Community
based TB/HIV integration by Alliance in
partnership with PATH
at
http://www.aidsalliance.org/Publication
sdetails.aspx?Id=90632
15
Introduction notes: I am very pleased to share Ukraine experience with you in this conference and would like to give an overview of civil society engagement in HIV/AIDS implementation in Ukraine.
- Ukraine is estimated at 350.000 people living with HIV. - However, officially registered numbers still far below than estimation Ukrainian epidemic is fueled by unsafe injecting drug use made of locally cultivated poppy seeds - WHO estimates, that 325 000 to 425 000 injecting drug users in Ukraine, and according to the data from the Ukrainian Centre of Disease Control, HIV prevalence in this group may vary from 17% to 70%. In the year 2012, there were a total of 29410 TB patients with known HIV status in Ukraine, which represents 95% of all TB cases. Of these TB patients, 4726 were reported to be HIV positive. - 17 110 patients were tested for MDR TB and out of which 6934 were confirmed. 6257 of them started treatment, which makes 90%.
The data are provided by the Center of Medical Statistics of the Ministry of Health of Ukraine. This slide demonstrates the growth and stabilizing ( 2010- 2012) of new HIV cases and overall decrease in TB cases; as you may see there was a peek of TB incident in 2006 with 84 per 100 000 and that has decreased to 68 in 2012. At the same time HIV has a steady increase until 2011 and started to fall slightly in 2011due to targeted intervention in most at risk groups specially people who inject drugs
If to compare Incidence and Mortality of TB/HIV co-infection, both incidents are growing in Ukraine in general. Growth in incidence because of the intensifyed case finding.
As you may see this is vertical healthcare system where decision, implementation and information are circulated in hierarchical order: Ministry of Health orders and requests go down to the Regional Healthcare Departments, which, in their turn, send relevant questions to all of the below-mentioned healthcare institutions, get answers and send them back to the Ministry of Health. There’s no single person or unit within regional healthcare departments responsible for “uniting” HIV and TB statistics; thus, the information on HIV/TB flows in parallel. At the end of 2012 an structural changes was initiated by the Minister of health by merging National TB and HIV centers under one management thus created a new institution named “Ukrainian Centre for Disease Control” (UCDC).
As you can see this health care reform will allowed the UCDC to manage and coordinate all activities related to HIV and TB including, development of protocol or methodological support, implementation, data collection and evaluation. This reform is still in transition however under the new operational policy UCDC aimed to organize the uniform HIV/TB policy in Ukraine and perform coordination between TB and AIDs health hare facilities.
National Level: Cross-sectoral HIV/TB working group (WG) Trilateral memorandum among Ukrainian AIDS Center, All-Ukrainian TB Control Center and Alliance; Biannual reporting meetings for TB and HIV program managers to share experience and plan joint activities. Technical support in creating proper terms and conditions for PITC (group and individual) in TB control institutions Development of the guidelines: - on conducting VCT among the patients of TB control facilities; - on preventive cotrimoxazol treatment for HIV/TB patients; - of the mechanisms for passing ART and SMT medications to the patients who are treated in in-patient units of TB control facilities. - Advocacy Regional Level: -Technical support – health system strengthening, grant support – integrated care, trainings on method guidance, integrated care etc..and advocacy
Vertical health care system State funding Lack of collaboration between services Rudimentary collaboration with health care facilities
Patients still face stigma and discrimination Lack of resources No partnership framework between health care facilities and CSO’s Very little collaboration exist at the moment